Simplex Trading
CUE icon

Simplex Trading’s Cue Biopharma CUE Stock Holding History

Simplex Trading’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-113
Closed -$3K – 8682
2024
Q4 		$3K Buy
+113
New +$4.25K ﹤0.01% 7857
2024
Q3 		– Sell
-2,937
Closed -$109K – 8649
2024
Q2 		$109K Buy
2,937
+1,544
+111% +$76.4K ﹤0.01% 5289
2024
Q1 		$79K Sell
1,393
-2,834
-67% -$200K ﹤0.01% 5826
2023
Q4 		$334K Buy
4,227
+2,570
+155% +$184K ﹤0.01% 4105
2023
Q3 		$114K Sell
1,657
-2,513
-60% -$245K ﹤0.01% 4951
2023
Q2 		$456K Buy
4,170
+3,477
+502% +$409K ﹤0.01% 3409
2023
Q1 		$74K Sell
693
-177
-20% -$16.9K ﹤0.01% 5491
2022
Q4 		$74K Buy
870
+733
+535% +$67K ﹤0.01% 5410
2022
Q3 		$9K Sell
137
-250
-65% -$21.5K ﹤0.01% 8304
2022
Q2 		$28K Sell
387
-806
-68% -$94.3K ﹤0.01% 7215
2022
Q1 		$174K Buy
1,193
+1,100
+1,183% +$233K ﹤0.01% 5346
2021
Q4 		$31K Sell
93
-414
-82% -$160K ﹤0.01% 7852
2021
Q3 		$186K Buy
507
+17
+3% +$5.93K ﹤0.01% 5712
2021
Q2 		$171K Buy
490
+489
+48,900% +$190K ﹤0.01% 5937
2021
Q1 		$25K Buy
+1
New +$412 ﹤0.01% 7264
2020
Q4 		– Hold
0
– – – 7957
2020
Q3 		– Hold
0
– – – 7530
2020
Q2 		– Hold
0
– – – 6070

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Simplex Trading's CUE Position: Q1 2026 in Review

Simplex Trading reduced its Cue Biopharma (CUE) stake by 66% in Q1 2026, selling an estimated $522 and leaving 29 shares worth $201. The position accounts for ﹤0.01% of the portfolio, ranked #8836.

Simplex Trading first reported a position in CUE in Q1 2020 and has held it in 18 quarters since. The position peaked at $130K in Q4 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Simplex Trading held 29 shares of Cue Biopharma worth $201 as of Q1 2026.
  • Simplex Trading sold 56 Cue Biopharma shares in Q1 2026, an estimated $522.
  • Cue Biopharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8836 holding.
  • Simplex Trading first reported a position in Cue Biopharma in Q1 2020 and has held it in 18 quarters since.
  • Simplex Trading's Cue Biopharma position peaked at $130K in Q4 2021.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.